Lamivudine 31722-0754
Product NDC
31722-0754- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 6, 2014
- Listing Expires
- December 31, 2026
- Application
- ANDA203277
Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Packaging Options(4)
600 TABLET, FILM COATED in 1 BOTTLE (31722-754-06)
30 TABLET, FILM COATED in 1 BOTTLE (31722-754-30)
10 TABLET, FILM COATED in 1 BLISTER PACK (31722-754-31)
100 TABLET, FILM COATED in 1 CARTON (31722-754-32)